Skip to Content

Advancements in SLE Management

Professor Anders Bengtsson from Lund University discusses recent progress in treating Systemic Lupus Erythematosus (SLE) at SCR 2023. He highlights the impact of disease activity on organ damage and discusses drug options, including combinations of belimumab, voclosporin, and anifrolumab.

Anders Bengtsson

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top